Verso em portugus

FAPESP and Agilent will fund research in BioPharma

FAPESP and Agilent will fund research in BioPharma

Projects that can advance the state of the art of measurements for BioPharma, for human health, veterinary medicine and agricultural research, will be funded (photo: Agilent)

The São Paulo Research Foundation (FAPESP) and Agilent announce a new call for proposals, with BioPharma as the main theme of interest. The opportunity is open to researchers associated to institutions of higher education or research, public or private, in the State of São Paulo.

The call aims at funding projects that can advance the state of the art of measurements for BioPharma, for human health, veterinary medicine and agricultural research. Specifically, in finding ways to make the discovery, development, and manufacture of biologics and biosimilars faster, easier, more robust and higher in quality.

Successful proposals can include refinement of instruments, development of new measurement protocols, new ways to analyze data, invention of new workflows, or applications of existing techniques to yield new biological understanding within the context of this call.

Expected outcomes of research projects would include, but not be limited to, academic peer-reviewed paper publications, web sites with information for the academic community, and presentation of findings at academic conferences.

The selected projects will have duration of up to 36 months. Proposals must meet the conditions and restrictions of the FAPESP Program for Cooperative Research for Technological Innovation (PITE). The last date for receiving proposals is February 20, 2020. 

The call for proposals is published at: www.fapesp.br/en/13656

 

Print | URL: fapesp.br/13667